Sharon Chen

Sharon Chen Xiao is the Founder and CEO of AlphaLife Sciences, where she is leading the transformation of life sciences through generative AI, automation, and advanced clinical technologies. She focuses on building intelligent platforms that accelerate drug development, improve regulatory processes, and enhance the efficiency of clinical operations.

With a strong foundation in engineering and enterprise technology, Sharon previously held senior leadership roles at companies including Google and Verily, where she worked at the intersection of technology, healthcare, and large-scale innovation.

At Google, she served in engineering leadership positions, contributing to the development of scalable systems and driving strategic initiatives across global teams. At Verily, Alphabet’s life sciences division, she played a key role in advancing digital health solutions and data-driven healthcare innovation.

As an entrepreneur, Sharon has built AlphaLife Sciences into a forward-thinking organization focused on leveraging GenAI to solve complex challenges in pharmaceutical and biotech industries. Her work enables faster clinical documentation, improved compliance, and more efficient research workflows.

She is widely recognized for her ability to bridge cutting-edge AI technologies with real-world healthcare applications, translating innovation into measurable impact. Her leadership combines deep technical expertise with a strong vision for the future of healthcare and life sciences.

Under her leadership, AlphaLife Sciences has gained industry recognition for its innovation-driven approach, including being featured in leading global platforms and innovation lists.

Passionate about advancing the role of AI in healthcare, Sharon continues to shape how organizations adopt next-generation technologies to drive efficiency, accuracy, and long-term value in a rapidly evolving industry.

‍